Therefore, it is conceivable that off-target inhibition of neuronal CDK5 (or other related kinases) by CDK4/6 inhibitors could disrupt normal neuronal function and contribute to the development of peripheral neuropathy in a subset of patients. Here, CDK4 is linked to peripheral neuropathy.